| Overview |
| bs-8324R-FITC |
| SERPINB13 Polyclonal Antibody, FITC Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human, Mouse, Rat, Dog, Cow, Horse |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Headpin/SERPINB13 |
| 101-200/391 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5275 |
| Cytoplasm |
| HaCaT UV-repressible serpin; Headpin; HSHUR7SEQ; HUR7; Hurpin; serpinB13; Peptidase inhibitor 13; PI-13; PI13; Protease inhibitor 13; Proteinase inhibitor 13; Serine or cysteine proteinase inhibitor clade B ovalbumin member 13; Serpin B13; Serpin peptidase inhibitor clade B ovalbumin member 13; SERPINB13; SPB13_HUMAN; UV B repressed sequence HUR 7. |
| Headpin is a skin-specific, UV-repressible serine proteinase inhibitor (serpin) belonging to the ovalbumin serpin family. Headpin is abundant in the human keratinocyte cell line HaCaT, and in lesional keratinocytes from psoriatic skin. Headpin downregulation occurs in squamous cell carcinoma of the oral cavity and in squamous cell carcinoma cell lines of the head and neck. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz